Age-Related Differences in Health-Related Quality of Life in COPD: An Analysis of the COPDGene and SPIROMICS Cohorts
- PMID: 26836895
- PMCID: PMC4944781
- DOI: 10.1016/j.chest.2015.11.025
Age-Related Differences in Health-Related Quality of Life in COPD: An Analysis of the COPDGene and SPIROMICS Cohorts
Abstract
Objective: Younger persons with COPD report worse health-related quality of life (HRQL) than do older individuals. The factors explaining these differences remain unclear. The objective of this article was to explore factors associated with age-related differences in HRQL in COPD.
Methods: Cross-sectional analysis of participants with COPD, any Global Initiative for Chronic Obstructive Lung Disease grade of airflow limitation, and ≥ 50 years old in two cohorts: the Genetic Epidemiology of COPD (COPDGene) study and the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS). We compared St. George's Respiratory Questionnaire (SGRQ) scores by age group: middle-aged (age, 50-64) vs older (age, 65-80) adults. We used multivariate linear modeling to test associations of age with HRQL, adjusting for demographic and clinical characteristics and comorbidities.
Results: Among 4,097 participants in the COPDGene study (2,170 middle-aged and 1,927 older adults) SGRQ total scores were higher (worse) among middle-aged (mean difference, -4.2 points; 95% CI, -5.7 to -2.6; P < .001) than older adults. Age had a statistically significant interaction with dyspnea (P < .001). Greater dyspnea severity (modified Medical Research Council ≥ 2, compared with 0-1) had a stronger association with SGRQ score among middle-aged (β, 24.6; 95% CI, 23.2-25.9) than older-adult (β, 21.0; 95% CI, 19.6-22.3) participants. In analyses using SGRQ as outcome in 1,522 participants in SPIROMICS (598 middle-aged and 924 older adults), we found similar associations, confirming that for the same severity of dyspnea there is a stronger association with HRQL among younger individuals.
Conclusions: Age-related differences in HRQL may be explained by a higher impact of dyspnea among younger subjects with COPD.
Trial registry: ClinicalTrials.gov; No.: NCT00608764 and No.: NCT01969344; URL: www.clinicaltrials.gov.
Keywords: COPD; aging; dyspnea; geriatrics; health status; obstructive lung disease; quality of life.
Copyright © 2016 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Figures



Similar articles
-
Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts.Respir Res. 2018 Jan 26;19(1):20. doi: 10.1186/s12931-018-0717-z. Respir Res. 2018. PMID: 29373977 Free PMC article.
-
Anemia and Adverse Outcomes in a Chronic Obstructive Pulmonary Disease Population with a High Burden of Comorbidities. An Analysis from SPIROMICS.Ann Am Thorac Soc. 2018 Jun;15(6):710-717. doi: 10.1513/AnnalsATS.201708-687OC. Ann Am Thorac Soc. 2018. PMID: 30726108 Free PMC article.
-
Different impacts of respiratory symptoms and comorbidities on COPD-specific health-related quality of life by COPD severity.Int J Chron Obstruct Pulmon Dis. 2017 Nov 13;12:3301-3310. doi: 10.2147/COPD.S145910. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 29180860 Free PMC article.
-
Combined aclidinium bromide and long-acting beta2-agonist for chronic obstructive pulmonary disease (COPD).Cochrane Database Syst Rev. 2018 Dec 11;12(12):CD011594. doi: 10.1002/14651858.CD011594.pub2. Cochrane Database Syst Rev. 2018. PMID: 30536566 Free PMC article.
-
Active mind-body movement therapies as an adjunct to or in comparison with pulmonary rehabilitation for people with chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2018 Oct 10;10(10):CD012290. doi: 10.1002/14651858.CD012290.pub2. Cochrane Database Syst Rev. 2018. PMID: 30306545 Free PMC article.
Cited by
-
Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies.Respir Res. 2016 Jul 12;17(1):81. doi: 10.1186/s12931-016-0401-0. Respir Res. 2016. PMID: 27405652 Free PMC article.
-
Consideration of Sex, Gender, or Age on Outcomes of Digital Technologies for Treatment and Monitoring of Chronic Obstructive Pulmonary Disease: Overview of Systematic Reviews.J Med Internet Res. 2023 Nov 29;25:e49639. doi: 10.2196/49639. J Med Internet Res. 2023. PMID: 38019578 Free PMC article. Review.
-
Relationship between Multimorbidity and Quality of Life in a Primary Care Setting: The Mediating Role of Dyspnea.J Clin Med. 2022 Jan 27;11(3):656. doi: 10.3390/jcm11030656. J Clin Med. 2022. PMID: 35160105 Free PMC article.
-
Factors associated with health-related quality of life among employed individuals with chronic obstructive pulmonary disease: A correlational study in China.Belitung Nurs J. 2023 Jun 26;9(3):271-279. doi: 10.33546/bnj.2654. eCollection 2023. Belitung Nurs J. 2023. PMID: 37492761 Free PMC article.
-
Long-Term SGRQ Stability in a Cohort of Individuals with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease.Int J Chron Obstruct Pulmon Dis. 2024 Apr 10;19:889-900. doi: 10.2147/COPD.S443183. eCollection 2024. Int J Chron Obstruct Pulmon Dis. 2024. PMID: 38617018 Free PMC article.
References
-
- Srivastava K., Thakur D., Sharma S., Punekar Y.S. Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease. Pharmacoeconomics. 2015;33(5):467–488. - PubMed
Publication types
MeSH terms
Associated data
Grants and funding
- HHSN268200900009C/WH/WHI NIH HHS/United States
- K08 AG031837/AG/NIA NIH HHS/United States
- HHSN268200900016C/HL/NHLBI NIH HHS/United States
- R01 HL122438/HL/NHLBI NIH HHS/United States
- HHSN268200900018C/HL/NHLBI NIH HHS/United States
- HHSN268200900013C/HL/NHLBI NIH HHS/United States
- 3R01HL122438-02S1/HL/NHLBI NIH HHS/United States
- HHSN268200900014C/HL/NHLBI NIH HHS/United States
- R01 HL089897/HL/NHLBI NIH HHS/United States
- HHSN268200900019C/HL/NHLBI NIH HHS/United States
- K23 HL128936/HL/NHLBI NIH HHS/United States
- K23 HL095658/HL/NHLBI NIH HHS/United States
- R01 HL089856/HL/NHLBI NIH HHS/United States
- K01 HL118714/HL/NHLBI NIH HHS/United States
- K01HL118714/HL/NHLBI NIH HHS/United States
- HHSN268200900015C/HL/NHLBI NIH HHS/United States
- HHSN268200900017C/HL/NHLBI NIH HHS/United States
- HHSN268200900020C/HL/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases